GBSI is dedicated to enhancing the quality of biomedical research by advocating best practices and standards to accelerate the translation of research breakthroughs into life-saving therapies.
Investing in Practical Solutions
For example, taking immediate steps in just two areas where there will be significant return on investment— study design and biological reagents—will yield substantial improvements in preclinical reproducibility rates.
With the implementation of standards, life sciences will benefit from the many advancements that will come with it.
The global community can no longer afford the economic and intellectual drain caused by irreproducible research.
Conservatively, 50% of published pre-clinical research is irreproducible, with an estimated annual cost of $28B in the United States alone.
Engage the research community in establishing community accepted standards and guidelines in specific scientific areas.
Continued transparent, global, multi-stakeholder engagement is the way forward to better, more impactful science.
"Standards can benefit all stakeholders, counteract quality challenges, and be a unifying driver of current and future life science research quality improvement efforts."
GBSI hosts a range of exciting events bringing the world's leading funders, researchers, journals, and other community stakeholders together.
GBSI provides a suite of online and onsite educational tools that benefits both individuals and organizations.
Catch up on GBSI in the news and our most recent publications and press releases.
Take a look at our initiatives to learn more about our goals to improve reproducibility in life sciences and how you can get involved.
* Citation: Freedman LP, Cockburn IM, Simcoe TS (2015) The Economics of Reproducibility in Preclinical Research. PLoS Biol 13(6): e1002165. doi:10.1371/journal.pbio.1002165